XML 203 R184.htm IDEA: XBRL DOCUMENT v3.8.0.1
Common Shareholders’ Equity (Details Textual)
 12 Months Ended
Dec. 31, 2017
CLP ($)
shares
Dec. 31, 2016
CLP ($)
shares
Dec. 31, 2008
CLP ($)
Dec. 31, 1979
CLP ($)
Dec. 31, 2017
$ / shares
Dec. 06, 2017
CLP ($)
Dec. 06, 2017
$ / shares
Apr. 12, 2017
CLP ($)
Apr. 12, 2017
$ / shares
Dec. 31, 2016
$ / shares
Dec. 06, 2016
CLP ($)
Dec. 06, 2016
$ / shares
Apr. 13, 2016
CLP ($)
Apr. 13, 2016
$ / shares
Dec. 31, 2015
CLP ($)
Dec. 31, 2015
$ / shares
Dec. 02, 2015
CLP ($)
Dec. 02, 2015
$ / shares
Apr. 15, 2015
CLP ($)
Apr. 15, 2015
$ / shares
Dec. 31, 2014
$ / shares
Dec. 02, 2014
CLP ($)
Dec. 02, 2014
$ / shares
Disclosure of Common Shareholders’ Equity [Line Items]                                              
Issued capital $ 562,693,346,000 $ 562,693,346,000                                          
Number of shares issued and fully paid | shares 369,502,872 369,502,872                                          
Description of dividend policy annually distributing at least 50% of the net distributable profit of the year                                            
Reserve of exchange differences on translation $ 153,541,761,000 $ 17,869,963,000                         $ 16,655,069,000                
Reserve of cash flow hedges 28,244,000 39,081,000                         2,526,000                
Reserve of remeasurements of defined benefit plans 3,958,511,000 3,925,717,000                         2,302,418,000                
Other reserves (178,075,279,000) (142,973,378,000)                         $ 5,486,086,000                
Increase decrease through adjustments due to reassessment of fixed assets       $ 4,087,396,000                                      
Increase decrease through adjustments of price level restatement of paid up capital     $ 17,615,333,000                                        
Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity $ (7,584,747,000) [1] $ (24,757,013,000) [2]                                          
Interim dividend [Member]                                              
Disclosure of Common Shareholders’ Equity [Line Items]                                              
Dividend payables           $ 25,865,201,000         $ 24,387,190,000           $ 24,387,190,000         $ 23,278,681,000  
Dividend per Share | $ / shares         $ 70.0000   $ 70     $ 66.0000   $ 66       $ 66.0000   $ 66     $ 63.0000   $ 63
Final dividend [Member]                                              
Disclosure of Common Shareholders’ Equity [Line Items]                                              
Dividend payables               $ 40,764,427,000         $ 36,016,878,000           $ 36,500,004,000        
Dividend per Share | $ / shares                 $ 110.32236 $ 110.32236       $ 97.47388   $ 97.47388       $ 98.78138 $ 98.78138    
Percentage of dividend distribution               34.41%                              
[1] During 2017, through its subsidiary CCU Inversiones S.A., the Company acquired an additional interest of VSPT for an amount of ThCh$ 7,800,000 with a carrying amount of ThCh$ 5,724,003, generated, at CCu's consolidated level, a decrease in Other reserves of ThCh$ 2,075,441.
[2] In 2016, the Company, through its subsidiaries Aguas CCU-Nestlé Chile S.A. and Embotelladoras Chilenas Unidas S.A., acquired an additional interest of Manantial S.A. for an amount of ThCh$ 19,111,686, with a carrying amount to ThCh$ 3,816,220, gererating in a decrease in Other reserves of ThCh$ 7,801,153 (see Note 1 (1)). Additionally, during 2016 the Company, through its subsidiary Compañía Industrial Cervecera S.A. acquired an additional interest in Los Huemules SRL. for an amount of ThCh$ 118,092, with a carrying amount of ThCh$ 312,103, resulting in an increase in Other reserves of ThCh$ 194,000 (see Note 1 (4)). Finally during 2016, the joint venture Foods acquired an additional interest in Alimentos Nutrabien S.A. for an amount of ThCh$ 14,352,706, with a carrying amount of ThCh$ 3,497,385, resulting in a decrease of ThCh$ 5,426,209.